Related Articles
Serum GP73 is complementary to AFP and GGT‑Ⅱ for the diagnosis of hepatocellular carcinoma
Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma
Upregulation of RECQL4 expression predicts poor prognosis in hepatocellular carcinoma
Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma